Literature DB >> 18952672

Ictal hypoxemia in localization-related epilepsy: analysis of incidence, severity and risk factors.

Lisa M Bateman1, Chin-Shang Li, Masud Seyal.   

Abstract

Ictal hypoxemia has been reported in small series of cases and may contribute to sudden unexpected death in epilepsy (SUDEP). We sought to determine the incidence and severity of ictal hypoxemia in patients with localization-related epilepsy undergoing in-patient video-EEG telemetry. We examined whether seizure-associated oxygen desaturation was a consequence of hypoventilation and whether factors such as seizure localization and lateralization, seizure duration, contralateral spread of seizures, patient position at seizure onset and body mass index influenced ictal-related hypoxemia. A total of 304 seizures with accompanying oxygen saturation data were recorded in 56 consecutive patients with intractable localization-related epilepsy; 51 of 304 seizures progressed to generalized convulsions. Pulse oximetry showed oxygen desaturations below 90% in 101 (33.2%) of all seizures with or without secondary generalization, with 31 (10.2%) seizures accompanied by desaturations below 80% and 11 (3.6%) seizures below 70%. The mean duration of desaturation below 90% was 69.2 +/- 65.2 s (47; 6-327). The mean oxygen saturation nadir following secondary generalization was 75.4% +/- 11.4% (77%; 42-100%). Desaturations below 90% were significantly correlated with seizure localization [P = 0.005; odds ratio (OR) of temporal versus extratemporal = 5.202; 95% CI = (1.665, 16.257)], seizure lateralization [P = 0.001; OR of right versus left = 2.098; 95% CI = (1.078, 4.085)], contralateral spread of seizures [P = 0.028; OR of contralateral spread versus no spread = 2.591; 95% CI = (1.112, 6.039)] and gender [P = 0.048; OR of female versus male = 0.422; 95% CI = (0.179, 0.994)]. In the subset of 253 partial seizures without secondary generalized convulsions, 34.8% of seizures had desaturations below 90%, 31.8% had desaturations below 80% and 12.5% had desaturations below 70%. The degree of desaturation was significantly correlated with seizure duration (P = 0.001) and with electrographic evidence of seizure spread to the contralateral hemisphere (P = 0.003). Central apnoeas or hypopnoeas occurred with 50% of 100 seizures. Mixed or obstructive apnoeas occurred with 9% of these seizures. End-tidal carbon dioxide (ETCO2) was recorded in seven patients (19 seizures). The mean increase in ETCO2 from preictal baseline was 18.6 +/- 17.7 mm Hg (13.2; 2.8-77.8). In these 19 seizures, all oxygen desaturations below 85% were accompanied by an increase in ETCO2. Ictal hypoxemia occurs often in patients with localization-related epilepsy and may be pronounced and prolonged; even with seizures that do not progress to generalized convulsions. Oxygen desaturations are accompanied by increases in ETCO2, supporting the assumption that ictal oxygen desaturation is a consequence of hypoventilation. Ictal hypoxemia and hypercapnia may contribute to SUDEP.

Entities:  

Mesh:

Year:  2008        PMID: 18952672      PMCID: PMC2639205          DOI: 10.1093/brain/awn277

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  22 in total

1.  Cardiovascular and respiratory responses to electrical and chemical stimulation of the hippocampus in anesthetized and awake rats.

Authors:  K G Ruit; E J Neafsey
Journal:  Brain Res       Date:  1988-08-09       Impact factor: 3.252

2.  Cardiac and respiratory correlations with unit discharge in epileptic human temporal lobe.

Authors:  R C Frysinger; R M Harper
Journal:  Epilepsia       Date:  1990 Mar-Apr       Impact factor: 5.864

3.  Anatomical evidence for a strong ventral parabrachial projection to nucleus raphe magnus and adjacent tegmental field.

Authors:  G Holstege
Journal:  Brain Res       Date:  1988-04-26       Impact factor: 3.252

4.  Oxygen desaturations triggered by partial seizures: implications for cardiopulmonary instability in epilepsy.

Authors:  A S Blum; J R Ives; A L Goldberger; I C Al-Aweel; K B Krishnamurthy; F W Drislane; D L Schomer
Journal:  Epilepsia       Date:  2000-05       Impact factor: 5.864

5.  Effects of hypercapnia on hemodynamic, inotropic, lusitropic, and electrophysiologic indices in humans.

Authors:  D G Kiely; R I Cargill; B J Lipworth
Journal:  Chest       Date:  1996-05       Impact factor: 9.410

6.  Hippocampal reflected optical patterns during sleep and waking states in the freely behaving cat.

Authors:  G R Poe; D M Rector; R M Harper
Journal:  J Neurosci       Date:  1994-05       Impact factor: 6.167

7.  Hypoxaemia and cardiorespiratory changes during epileptic seizures in young children.

Authors:  J Hewertson; S G Boyd; M P Samuels; B G Neville; D P Southall
Journal:  Dev Med Child Neurol       Date:  1996-06       Impact factor: 5.449

Review 8.  Serotonin receptors: guardians of stable breathing.

Authors:  Diethelm W Richter; Till Manzke; Bernd Wilken; Evgeni Ponimaskin
Journal:  Trends Mol Med       Date:  2003-12       Impact factor: 11.951

9.  Apnoea and bradycardia during epileptic seizures: relation to sudden death in epilepsy.

Authors:  L Nashef; F Walker; P Allen; J W Sander; S D Shorvon; D R Fish
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-03       Impact factor: 10.154

10.  EEG and ECG in sudden unexplained death in epilepsy.

Authors:  Maromi Nei; Reginald T Ho; Bassel W Abou-Khalil; Frank W Drislane; Joyce Liporace; Alicia Romeo; Michael R Sperling
Journal:  Epilepsia       Date:  2004-04       Impact factor: 5.864

View more
  91 in total

1.  Amygdala and hippocampus are symptomatogenic zones for central apneic seizures.

Authors:  Nuria Lacuey; Bilal Zonjy; Luisa Londono; Samden D Lhatoo
Journal:  Neurology       Date:  2017-01-13       Impact factor: 9.910

Review 2.  Abnormalities of serotonergic neurotransmission in animal models of SUDEP.

Authors:  Hua-Jun Feng; Carl L Faingold
Journal:  Epilepsy Behav       Date:  2015-08-10       Impact factor: 2.937

3.  Nocturnal seizures are associated with more severe hypoxemia and increased risk of postictal generalized EEG suppression.

Authors:  Véronique Latreille; Myriam Abdennadher; Barbara A Dworetzky; Judith Ramel; David White; Eliot Katz; Marcin Zarowski; Sanjeev Kothare; Milena Pavlova
Journal:  Epilepsia       Date:  2017-07-17       Impact factor: 5.864

Review 4.  Epidemiology and pathophysiology of autonomic seizures: a systematic review.

Authors:  Christoph Baumgartner; Johannes Koren; Martha Britto-Arias; Simone Schmidt; Susanne Pirker
Journal:  Clin Auton Res       Date:  2019-02-25       Impact factor: 4.435

5.  Impaired central respiratory chemoreflex in an experimental genetic model of epilepsy.

Authors:  Leonardo T Totola; Ana C Takakura; José Antonio C Oliveira; Norberto Garcia-Cairasco; Thiago S Moreira
Journal:  J Physiol       Date:  2016-10-27       Impact factor: 5.182

6.  Seizure-associated central apnea in a rat model: Evidence for resetting the respiratory rhythm and activation of the diving reflex.

Authors:  S M Villiere; K Nakase; R Kollmar; J Silverman; K Sundaram; M Stewart
Journal:  Neurobiol Dis       Date:  2017-01-31       Impact factor: 5.996

7.  Breathing new life into the fight against sudden death in epilepsy.

Authors:  Lawrence J Hirsch
Journal:  Epilepsy Curr       Date:  2009 Sep-Oct       Impact factor: 7.500

8.  A human amygdala site that inhibits respiration and elicits apnea in pediatric epilepsy.

Authors:  Ariane E Rhone; Christopher K Kovach; Gail Is Harmata; Alyssa W Sullivan; Daniel Tranel; Michael A Ciliberto; Matthew A Howard; George B Richerson; Mitchell Steinschneider; John A Wemmie; Brian J Dlouhy
Journal:  JCI Insight       Date:  2020-03-26

Review 9.  An explanation for sudden death in epilepsy (SUDEP).

Authors:  Mark Stewart
Journal:  J Physiol Sci       Date:  2018-03-14       Impact factor: 2.781

Review 10.  Autonomic aspects of sudden unexpected death in epilepsy (SUDEP).

Authors:  Niravkumar Barot; Maromi Nei
Journal:  Clin Auton Res       Date:  2018-11-19       Impact factor: 4.435

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.